Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 9762472)

1.
2.
3.

Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia.

Seitz U, Neumaier B, Glatting G, Kotzerke J, Bunjes D, Reske SN.

Eur J Nucl Med. 1999 Oct;26(10):1265-73.

PMID:
10541824
4.

Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.

Langley RR, Carlisle R, Ma L, Specian RD, Gerritsen ME, Granger DN.

Microcirculation. 2001 Oct;8(5):335-45.

PMID:
11687945
5.
7.

123Iodine-labelled anti-VCAM-1 antibody scintigraphy in the assessment of experimental colitis.

Sans M, Fuster D, Vázquez A, Setoain FJ, Piera C, Piqué JM, Panés J.

Eur J Gastroenterol Hepatol. 2001 Jan;13(1):31-8.

PMID:
11204806
8.

Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.

Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC.

J Nucl Med. 2004 Feb;45(2):327-37.

9.

Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting.

Danilov SM, Gavrilyuk VD, Franke FE, Pauls K, Harshaw DW, McDonald TD, Miletich DJ, Muzykantov VR.

Am J Physiol Lung Cell Mol Physiol. 2001 Jun;280(6):L1335-47.

10.

Targeting strategies for cancer radiotherapy.

Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.

Clin Cancer Res. 1999 Oct;5(10 Suppl):3048s-3055s.

PMID:
10541342
11.

Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.

Moustapha ME, Ehrhardt GJ, Smith CJ, Szajek LP, Eckelman WC, Jurisson SS.

Nucl Med Biol. 2006 Jan;33(1):81-9.

PMID:
16459262
13.

The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo.

Kennel SJ, Woodward JD, Rondinone AJ, Wall J, Huang Y, Mirzadeh S.

Nucl Med Biol. 2008 May;35(4):501-14. doi: 10.1016/j.nucmedbio.2008.02.001. Epub 2008 Apr 3.

PMID:
18482688
14.

Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice.

Burns RC, Rivera-Nieves J, Moskaluk CA, Matsumoto S, Cominelli F, Ley K.

Gastroenterology. 2001 Dec;121(6):1428-36.

PMID:
11729122
15.

Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.

Lahorte CM, Bacher K, Burvenich I, Coene ED, Cuvelier C, De Potter C, Thierens H, Van de Wiele C, Dierckx RA, Slegers G.

J Nucl Med. 2004 Jun;45(6):1065-73.

16.

Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.

J Nucl Med. 2004 Oct;45(10):1776-83.

17.

Biodistribution of indium-111-labeled antibody directed against intercellular adhesion molecule-1.

Sasso DE, Gionfriddo MA, Thrall RS, Syrbu SI, Smilowitz HM, Weiner RE.

J Nucl Med. 1996 Apr;37(4):656-61.

18.

Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.

van Schaijk FG, Oosterwijk E, Soede AC, Oyen WJ, McBride WJ, Griffiths GL, Goldenberg DM, Corstens FH, Boerman OC.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3880S-5S.

19.

Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.

Chen J, Cheng Z, Owen NK, Hoffman TJ, Miao Y, Jurisson SS, Quinn TP.

J Nucl Med. 2001 Dec;42(12):1847-55.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk